The Effect of Human Umbilical Cord Mesenchymal Stem Cell on Premature Ovarian Cell Senilism Through miR-10a

References

• Shareghi-Oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther. 2021;12(1):454. doi:10.1186/s13287-021-02529-w
   PubMedGoogle Scholar
• Chen L, Guo S, Wei C, Li H, Wang H, Xu Y. Effect of stem cell transplantation of premature ovarian failure in animal models and patients: a meta-analysis and case report. Exp Ther Med. 2018;15(5):4105–4118. doi:10.3892/etm.2018.5970
   PubMed Web of Science ®Google Scholar
• Lew R. Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2019;55:2–13. doi:10.1016/j.bpobgyn.2018.05.005
   PubMed Web of Science ®Google Scholar
• Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure. Stem Cell Rev Rep. 2023;19(3):651–666. doi:10.1007/s12015-022-10493-y
   PubMed Web of Science ®Google Scholar
• Thaweesapphithak S, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Roytrakul S, Manochantr S. Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord. Stem Cell Res Ther. 2019;10(1):79. doi:10.1186/s13287-019-1175-3
   PubMedGoogle Scholar
• Wang Z, Wang Y, Yang T, Li J, Yang X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017;8(1):11. doi:10.1186/s13287-016-0458-1
   PubMedGoogle Scholar
• Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858. doi:10.1002/stem.2575
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Fu YX, Ji J, Shan F, Li J, Hu R. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities. Stem Cell Res Ther. 2021;12(1):161. doi:10.1186/s13287-021-02212-0
   PubMed Web of Science ®Google Scholar
• Liu T, Liu Y, Huang Y, et al. miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells. Free Radic Biol Med. 2019;141:383–392. doi:10.1016/j.freeradbiomed.2019.07.010
   PubMed Web of Science ®Google Scholar
• Liu T, Li Q, Wang S, Chen C, Zheng J. Transplantation of ovarian granulosa‑like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol Med Rep. 2016;13(6):5053–5058. doi:10.3892/mmr.2016.5191
   PubMed Web of Science ®Google Scholar
• Sun B, Ma Y, Wang F, Hu L, Sun Y. miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis. Stem Cell Res Ther. 2019;10(1):360. doi:10.1186/s13287-019-1442-3
   PubMed Web of Science ®Google Scholar
• Ghadami M, El-Demerdash E, Zhang D, et al. Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. PLoS One. 2012;7(3):e32462. doi:10.1371/journal.pone.0032462
   PubMed Web of Science ®Google Scholar
• Mantawy EM, Said RS, Abdel-Aziz AK. Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: emphasis on TGF-β/MAPKs signaling pathway. Biomed Pharmacother. 2019;109:293–303. doi:10.1016/j.biopha.2018.10.092
   PubMed Web of Science ®Google Scholar
• Boots CE, Jungheim ES. Inflammation and human ovarian follicular dynamics. Semin Reprod Med. 2015;33(4):270–275. doi:10.1055/s-0035-1554928
   PubMed Web of Science ®Google Scholar
• Wei JH, Yuan XY, Zhang JM, Wei JQ. Caspase activity and oxidative stress of granulosa cells are associated with the viability and developmental potential of vitrified immature oocytes. Eur J Obstet Gynecol Reprod Biol. 2016;198:22–26. doi:10.1016/j.ejogrb.2015.12.010
   PubMed Web of Science ®Google Scholar
• Wang S, Yu L, Sun M, et al. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed Res Int. 2013;2013:690491. doi:10.1155/2013/690491
   PubMed Web of Science ®Google Scholar
• Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol. 2015;46(1):17–27. doi:10.3892/ijo.2014.2712
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi:10.1016/j.gpb.2015.02.001
   PubMed Web of Science ®Google Scholar
• Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014;3(1). doi:10.3402/jev.v3.23743
   PubMedGoogle Scholar
• Yang M, Lin L, Sha C, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Invest. 2020;100(3):342–352. doi:10.1038/s41374-019-0321-y
   PubMed Web of Science ®Google Scholar
• Xiao GY, Cheng CC, Chiang YS, Cheng WT, Liu IH, Wu SC. Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep. 2016;6(1):23120. doi:10.1038/srep23120
   PubMedGoogle Scholar
• Jiajie T, Yanzhou Y, Hoi-Hung AC, Zi-Jiang C, Wai-Yee C. Conserved miR-10 family represses proliferation and induces apoptosis in ovarian granulosa cells. Sci Rep. 2017;7(1):41304. doi:10.1038/srep41304
   PubMedGoogle Scholar